Syntis

Provider of drug compounding services

placeBoston, Massachusetts, United States calendar_todayFounded 2021 groups9 employees language syntis.bio

Registered entities

Social engagement

Social engagement: 3.8K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Cerberus Capital Management.

Investor typeCountShare
Venture capital325%
Private equity18%
Accelerator & incubator18%
Other / undisclosed758%

Recent activity

21 Jun 2026
Event
BIO 2026
9 Jun 2026
Leadership hire
Chief Financial Officer
16 Mar 2026
Event
Bioeurope/BioeuropeSpring
Coming soon